NXP


Q1 22: Overcapacity, priced in but still not in sight

03/05/22 -"NXP published record figures for the 7th quarter in a row. As the much feared “overcapacity” rumors resurface, NXP has proven once again that this is hardly an immediate issue. The backlog already ..."

Pages
44
Language
English
Published on
03/05/22
You may also be interested by these reports :
22/04/24
Upgrade to Buy – High uncertainty – Start over from scratch…

18/04/24
ASML has published Q1 sales figures in-line with our expectations although the new booking figures missed the market consensus. China still accounted ...

05/04/24
As an industrial conglomerate, Aalberts (Add; Netherlands) offers shareholders access to four distinct end-markets: eco-friendly buildings ...

03/04/24
Gross proceeds of CHF 206.75mn with successful capital increase

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO